Male pattern baldness is driven by a combination of genetics and hormones, specifically the way your hair follicles respond to a hormone called dihydrotestosterone, or DHT. Two-thirds of men experience noticeable hair loss by age 35, and by 50, roughly 85% have significant thinning. It’s the most common form of hair loss in men, and understanding what’s actually happening at the follicle level helps explain why it follows such a predictable pattern.
How DHT Shrinks Hair Follicles
Testosterone circulates through every man’s body, but not all men go bald. The difference comes down to what happens when an enzyme converts testosterone into DHT, a more potent form of the hormone. DHT binds to androgen receptors on hair follicles in specific areas of the scalp, particularly the temples, crown, and frontal hairline. When it locks onto these receptors, it enters the cell’s nucleus and triggers changes that gradually shrink the follicle.
This shrinking process is called miniaturization, and it doesn’t happen slowly and evenly. Research suggests it occurs in a few relatively large steps between growth cycles rather than as a smooth, gradual decline. Each time a follicle cycles through its growth phase, DHT signaling causes the dermal papilla (the cluster of cells at the base of the follicle that controls hair growth) to lose cells. Fewer cells means a smaller papilla, which produces a thinner, shorter, lighter hair. Over several cycles, what was once a thick terminal hair becomes a fine, nearly invisible vellus hair, and eventually the follicle stops producing visible hair altogether.
Why the Growth Cycle Speeds Up
Hair normally grows in three phases: a long growth phase (anagen), a short transition phase, and a resting phase (telogen) before the hair sheds and a new one begins. Anagen typically lasts two to six years, which is why scalp hair can grow so long. In male pattern baldness, DHT progressively shortens the anagen phase. A follicle that once grew hair for years may only sustain growth for weeks or months.
Because affected hairs cycle much more quickly, many more follicles are in the resting phase at any given time. This is why thinning areas look sparse even before follicles fully shut down. You’re not just growing thinner hairs; you’re growing them for a fraction of the time, so they never reach meaningful length before falling out and starting the cycle over again. The combination of shorter growth periods and progressively smaller follicles is what creates the visible thinning pattern.
The Genetic Component
Your genes determine how sensitive your follicles are to DHT, and the primary culprit sits on the X chromosome. The androgen receptor (AR) gene controls how androgen receptors are built and how strongly they respond to DHT. A landmark study in the Journal of Investigative Dermatology found that a specific variant of this gene appeared in 98% of young bald men compared to only 77% of men with no hair loss. Shorter repeat sequences within the gene were also more common in balding men, suggesting these variations make the receptor more active.
Because the AR gene is on the X chromosome, which men inherit from their mothers, there’s truth to the old observation that baldness often follows the maternal line. But it’s not the whole picture. Male pattern baldness is polygenic, meaning multiple genes contribute. Researchers have identified variants on other chromosomes that also play a role, which is why you can inherit baldness tendencies from your father’s side too. Having a father or maternal grandfather with significant hair loss increases your odds, but the pattern isn’t perfectly predictable because so many genetic variables interact.
Interestingly, the genes encoding the enzymes that convert testosterone to DHT don’t appear to differ between bald and non-bald men. The problem isn’t that balding men produce more DHT systemically. It’s that their follicles are genetically programmed to overreact to normal DHT levels. A balding scalp shows both higher local DHT concentrations and increased expression of androgen receptors, creating a double hit at the follicle.
Where and Why the Pattern Forms
The “pattern” in male pattern baldness exists because not all scalp follicles carry the same density of androgen receptors. Follicles at the temples, crown, and frontal scalp are loaded with them, while follicles along the sides and back of the head are largely resistant to DHT. This is why the horseshoe-shaped ring of hair that remains in advanced baldness is so consistent across men, and why hair transplant surgeons can move those resistant follicles to thinning areas with lasting results.
The Norwood scale classifies male pattern baldness into seven stages. Stage 1 shows no significant loss. Stage 2 involves slight recession at the temples. From there, the pattern typically progresses in one of two ways: the classic version, where temple recession deepens while a bald spot develops at the crown and the two areas eventually merge, or the less common “class A” variation, where the hairline recedes uniformly from front to back without a separate bald spot forming at the crown. Most men fall somewhere along the classic progression, though how far and how fast it advances varies enormously.
What Doesn’t Cause It
Wearing hats, using certain shampoos, and poor scalp circulation are commonly blamed, but none of these cause male pattern baldness. Two studies of identical twins found no association between hat wearing and worsening hair loss. In fact, one study of 92 male twins found that daily hat wearers actually experienced less temple recession than their non-hat-wearing twins, possibly because hats protect against sun damage. Stress can cause temporary hair shedding (a different condition called telogen effluvium), but it doesn’t trigger the permanent follicle miniaturization that defines male pattern baldness.
How Current Treatments Target the Cause
The two most established treatments work by addressing the hormonal mechanism directly or by stimulating follicles independently of it. One approach blocks the enzyme that converts testosterone to DHT, reducing DHT levels in the blood by about 70%. A more potent version of this approach blocks both forms of the enzyme and can reduce DHT levels by roughly 90%. Lower DHT means less signaling to vulnerable follicles, which can slow miniaturization and, in some cases, allow partially miniaturized follicles to recover.
The other established approach uses a topical treatment that opens potassium channels in the follicle cells. The exact mechanism is still being clarified, but it appears to stimulate follicle activity directly, independent of hormones. This makes it useful as a standalone option or in combination with DHT-blocking treatments. Neither approach can resurrect follicles that have fully shut down, which is why starting treatment earlier, while follicles are still miniaturizing rather than completely dormant, tends to produce better results.
Newer research has explored treatments that target the resting phase of the hair cycle rather than the hormonal trigger. One class of compounds appears to work by reducing localized inflammation around dormant follicles, which removes a barrier to stem cell activation and pushes resting follicles back into the growth phase. Early clinical testing showed continued hair count increases over six months of use, and because the approach is nonhormonal, it could potentially be combined with existing therapies. These treatments are still in development, but they represent a fundamentally different strategy from blocking DHT.
Reversing miniaturization requires rebuilding the dermal papilla. For follicles that have lost significant papillary cells, new cells must be recruited before a thicker growth cycle can begin. This biological reality is why recovery is slow even with effective treatment. Visible improvement typically takes six to twelve months, and any gains require ongoing treatment to maintain.